The Light Must Unite Declares November 11th as International Prayer Day for Global Peace 
SDoH Advocate Lori Petersen Joins SIREN Gravity Project Development Team
TROY, N.Y., May 2, 2019 /PRNewswire/ -- Alliance for Better Health, engaging medical and social service providers in promoting the health...
Major Life Sciences and Healthcare Companies Join Chronicled’s MediLedger Project Working Group
SAN FRANCISCO, May 2, 2019 /PRNewswire/ -- Leading life sciences and healthcare companies Pfizer Inc., McKesson Corporation, AmerisourceBergen Corporation, and Premier...
CirrusMD Announces $15 Million in Series B Funding and New Plans to Improve Care Delivery For Veteran Population
DENVER, May 2, 2019 /PRNewswire/ -- CirrusMD, a chat-first virtual care solution, today announced that it has raised $15 million in...
DowDuPont Reports First Quarter 2019 Results
WILMINGTON, Del., May 2, 2019 /PRNewswire/ -- 1Q19 GAAP EPS from Continuing Operations of $0.23; Adjusted EPS of $0.84 1Q19...
EarPeace Celebrates Better Hearing Month, Announces One-for-One Partnerships With Movement and Berklee College Of Music
BOSTON and DETROIT, May 1, 2019 /PRNewswire/ -- Hearing loss is now the third most common health problem in the...
Hercules Capital Reports First Quarter 2019 Financial Results
Achieved New Debt and Equity Commitments of $414.8 Million, up 56.0% Year-over-Year Grew Debt Investment Portfolio by $160.5 Million, Leading...
CPSI Announces First Quarter 2019 Results
Highlights for First Quarter 2019: Revenues of $69.1 million; GAAP net income of $3.4 million and non-GAAP net income of...
CONMED Corporation to Present at the Bank of America Merrill Lynch Healthcare Conference
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NASDAQ: CNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will...
Apollo Endosurgery, Inc. Reports First Quarter 2019 Results
Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. ("Apollo")...
NeuroPace to Present Data from Studies of the RNS System at American Academy of Neurology 2019 Annual Meeting
Presentations to highlight nine-year treatment outcomes and research on the potential use of electrographic data to identify RNS System responders...
LG Tackles Asthma & Allergy Awareness Month With ‘Home Free’ Campaign
ENGLEWOOD CLIFFS, N.J., May 2, 2019 /PRNewswire/ -- LG Electronics USA is joining forces with the Asthma and Allergy Foundation of America...
Invitation to MorphoSys Q1 2019 Conference Call on May 8, 2019
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / May 2, 2019 / MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; Nasdaq:...
Avinger to Announce First Quarter 2019 Financial Results on May 8, 2019
REDWOOD CITY, CA / ACCESSWIRE / May 2, 2019 / Avinger, Inc. (NASDAQ: AVGR), a commercial-stage medical device company marketing...
Medical Economics® Named Regional Winner and National Finalist for 2019 Azbee Awards of Excellence
“Surviving Merger Mania” is a finalist in the feature article — general interest category CRANBURY, N.J.--(BUSINESS WIRE)--Medical Economics®, a multimedia...
International Cannabrands Announces New Appointments to Management Team and Comments on Year End Results
DENVER, CO / ACCESSWIRE / May 2, 2019 / International Cannabrands Inc. (CSE: JUJU) (the 'Company') is pleased to announce...
Viveve to Host Conference Call to Discuss First Quarter 2019 Financial and Operating Results on May 9, 2019
ENGLEWOOD, CO / ACCESSWIRE / May 2, 2019 / Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on...
Preferred Dental Technologies Inc. (”Company”) (CSE: PDTI, US OTC: PDTTF): EAS Custom Dental Abutment System Receives Positive Review from Industry Legend
WINNIPEG, MB / ACCESSWIRE / May 2, 2019 / Preferred Dental Technologies Inc. ("Company") (CSE: PDTI, US OTC: PDTTF): EAS...
EyeGate Files IDE with FDA for PRK Pivotal Study
WALTHAM, MA / ACCESSWIRE / May 2, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (''EyeGate'' or ''the Company'') announced today...
VistaGen Reports Top Line Results from NIMH’s Exploratory Study of AV-101 Monotherapy for Treatment-Resistant Depression
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / May 2, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing...
Avolynt, Inc. Announces First Marketing Authorization and Commercial Launch of Novel SGLT2 Inhibitor Remogliflozin Etabonate for Type 2 Diabetes
RESEARCH TRIANGLE PARK, NC / ACCESSWIRE / May 2, 2019 / Avolynt, Inc., a company focused on the development of...